A detailed history of Ameriprise Financial Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 13,861 shares of CLPT stock, worth $159,817. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,861
Previous 41,316 66.45%
Holding current value
$159,817
Previous $635,000 74.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$11.89 - $18.8 $326,439 - $516,154
-27,455 Reduced 66.45%
13,861 $164,000
Q4 2024

Feb 14, 2025

BUY
$10.74 - $16.68 $29,449 - $45,736
2,742 Added 7.11%
41,316 $635,000
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $204,442 - $508,405
38,574 New
38,574 $432,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $282M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.